Recombinant alphavirus-based vectors with reduced inhibition...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/86 (2006.01) A61K 48/00 (2006.01) C07K 14/18 (2006.01) C12N 5/10 (2006.01) C12N 7/00 (2006.01) C12N 7/01 (2006.01) C12N 15/40 (2006.01) C12N 15/67 (2006.01) C12N 15/79 (2006.01)

Patent

CA 2304350

Isolated nucleic acid molecules are disclosed, comprising an alphavirus nonstructural protein gene which, when operably incorporated into a recombinant alphavirus particle, eukaryotic layered vector initiation system, or RNA vector replicon, has a reduced level of vector-specific RNA synthesis, as compared to wild-type, and the same or greater level of proteins encoded by RNA transcribed from the viral junction region promoter, as compared to a wild- type recombinant alphavirus particle. Also disclosed are RNA vector replicons, alphavirus vector constructs, and eukaryotic layered vector initiation systems which contain the above-identified nucleic acid molecules.

L'invention concerne des molécules isolées d'acide nucléique comprenant un gène protéine non structural d'alphavirus qui, lorsqu'il est incorporé de manière opérable, dans une particule d'alphavirus recombinante, un système d'initiation à vecteur stratifié eucaryotique ou un réplicon à vecteur ARN, présente un niveau réduit de synthèse à vecteur spécifique ARN, comparativement au type sauvage, et le même niveau, ou un niveau plus élevé de protéines codant pour ARN transcrites par le promoteur de la région de jonction virale, comparativement à une particule d'alphavirus recombinant de type sauvage. L'invention concerne également des réplicons à vecteur ARN, des édifices à vecteur d'alphavirus, ainsi que des systèmes d'initiation à vecteur stratifié eucaryotique contenant les molécules identifiées précitées d'acide nucléique,

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant alphavirus-based vectors with reduced inhibition... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant alphavirus-based vectors with reduced inhibition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant alphavirus-based vectors with reduced inhibition... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1737295

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.